| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $8,250,009 | 3 | 100 |
Sells | $0 | 0 | 0 |
| Chen Hung-Wen | Chief Executive Officer | 1 | $7.55M | 0 | $0 | $7.55M |
| LIN PETER KUAN-HOW | Chief Financial Officer | 1 | $400,005 | 0 | $0 | $400,005 |
| Chen Yi-Kuei | Chief Operating Officer | 1 | $300,000 | 0 | $0 | $300,000 |
Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development …
Over the last 12 months, insiders at Apollomics, Inc. have bought $8.25M and sold $0 worth of Apollomics, Inc. stock.
On average, over the past 5 years, insiders at Apollomics, Inc. have bought $8.25M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Chen Hung-Wen (Chief Executive Officer) — $7.55M. LIN PETER KUAN-HOW (Chief Financial Officer) — $400,005. Chen Yi-Kuei (Chief Operating Officer) — $300,000.
The last purchase of 536,667 shares for transaction amount of $7.55M was made by Chen Hung-Wen (Chief Executive Officer) on 2026‑08‑14.
| 2026-08-14 | Chen Hung-Wen | Chief Executive Officer | 536,667 76.6388% | $14.07 | $7.55M | -0.89% | ||
| 2026-08-14 | Chen Yi-Kuei | Chief Operating Officer | 20,000 3.0453% | $15.00 | $300,000 | -0.89% | ||
| 2026-08-14 | LIN PETER KUAN-HOW | Chief Financial Officer | 26,667 4.0604% | $15.00 | $400,005 | -0.89% |
| Increased Positions | 2 | +40% | 4,428 | +5,148.84% |
| Decreased Positions | 2 | -40% | 60 | -69.77% |
| New Positions | <1 | New | 4,380 | New |
| Sold Out Positions | <1 | Sold Out | 50 | Sold Out |
| Total Postitions | 5 | 0% | 4,454 | +5,079.07% |